Salbutamol Completed Phase 2 Trials for Clinically Significant Increase in Maximum Expiratory Volume Per Second / Chronic Respiratory Failure Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01958814Beta Agonist Nebulization in Non Invasively Ventilated COPD Patients: Safety, and Therapeutic Efficacy Range.